CCL2 and Alzheimer disease: Interestingly, levels of the chemokine CCL2 were elevated in the disease models where these cells have been described such as EAE, cuprizone induced demyelination as well as AD (Mahad and Ransohoff, 2003; Janelsins et al., 2005; Buschmann et al., 2012).